Abstract
Most cases of TBE in childhood will present similarly as in adults. However, a more diffuse clinical picture is seen especially in preschool children. Laboratory evaluation may show elevated blood inflammatory indices, but cerebrospinal fluid analysis and anti-TBEV serology are needed for establishing the diagnosis. There is no specific treatment for TBE; supportive care needs to be provided based on the individual clinical course. The mortality in pediatric TBE is very low, but severe courses have been reported in a fraction of the children. Long-term somatic residua exist, but are uncommon (2%) in childhood TBE. Yet, long-term symptoms and neurodevelopmental/cognitive deficits are seen in 10–40% of infected children. Protective immunity can be elicited in children by TBE vaccines as of 1 year of age.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
